https://regulatorynews.com/awiqli-pediatric-type2-diabetes-approval Regulatory News en 2026-10-27T06:02:18-04:00 FDA Approves Weekly Insulin Awiqli for Pediatric T2D https://regulatorynews.com/biomerieux-spotfire-vaginitis-fda-clearance Regulatory News en 2026-10-27T06:02:18-04:00 FDA Clears bioMérieux’s Point-of-Care Vaginitis Panel https://regulatorynews.com/fda-cosmetics-mandatory-recall-guidance Regulatory News en 2026-10-27T06:02:18-04:00 FDA Finalizes Its Mandatory Cosmetics Recall Guidance https://regulatorynews.com/hibsago-bepirovirsen-hepatitis-b-physicians Regulatory News en 2026-10-26T10:58:33-04:00 FDA Approves Hibsago, First Antisense Hepatitis B Drug https://regulatorynews.com/orladeyo-pellets-12-and-older-physicians Regulatory News en 2026-10-26T10:58:33-04:00 FDA Extends Orladeyo Pellets to Teens, Adults With HAE https://regulatorynews.com/city-therapeutics-nasdaq-ipo-rnai-financing Regulatory News en 2026-10-26T10:00:20-04:00 City Therapeutics Closes $230M Nasdaq IPO https://regulatorynews.com/rivanna-boneenhance-fda-clearance Regulatory News en 2026-10-26T10:00:20-04:00 RIVANNA Wins FDA Clearance for BoneEnhance AI https://regulatorynews.com/teleflex-freesolve-rms-coronary-breakthrough-designation Regulatory News en 2026-10-26T10:00:20-04:00 Teleflex's Freesolve Scaffold Wins 2nd Breakthrough Tag https://regulatorynews.com/biocryst-orladeyo-pellets-age-expansion Regulatory News en 2026-10-26T06:08:37-04:00 FDA Extends Orladeyo Pellets to Patients 12 and Up https://regulatorynews.com/fda-olympus-import-alert-gi-expansion Regulatory News en 2026-10-26T06:08:37-04:00 FDA Widens Olympus Import Alert to GI Scopes https://regulatorynews.com/safe-medicines-peptide-compounding-petition Regulatory News en 2026-10-26T06:08:37-04:00 Safety Group Asks FDA to Block Peptide Compounding https://regulatorynews.com/penumbra-lightning-cavt-dvt-physicians Regulatory News en 2026-10-25T10:54:16-04:00 FDA Clears Lightning CAVT for Deep Vein Thrombosis https://regulatorynews.com/ultomiris-iga-nephropathy-physicians Regulatory News en 2026-10-25T10:54:16-04:00 Ultomiris Cleared for IgAN; Kidney Benefit Still Unproven https://regulatorynews.com/nuravax-av1959r-fast-track-designation Regulatory News en 2026-10-25T09:39:40-04:00 Nuravax Wins FDA Fast Track for Alzheimer's Vaccine https://regulatorynews.com/penumbra-lightning-cavt-dvt-clearance Regulatory News en 2026-10-25T09:39:40-04:00 Penumbra's Lightning CAVT Clears FDA for DVT